Published in
Elsevier, The Lancet Respiratory Medicine, 10(3), p. 761-768, 2015
DOI: 10.1016/s2213-2600(15)00320-3
Links
Tools
Cardiovascular and neuropsychiatric risks of varenicline: A retrospective cohort study
Journal article published in 2015 by
Daniel Kotz,
Wolfgang Viechtbauer,
Colin Simpson 
,
Onno C. P. van Schayck,
Robert West,
Aziz Sheikh
,
Onno C. P. van Schayck,
Robert West,
Aziz Sheikh
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Varenicline is an effective pharmacotherapy to aid smoking cessation. However, its use is limited by continuing concerns about possible associated risks of serious adverse cardiovascular and neuropsychiatric events. The aim of this study was to investigate whether use of varenicline is associated with such events.